首页> 外文期刊>Nepal Journal of Neuroscience >Clinical Experience with Frameless Neuronavigation Guided Biopsy for Intracranial Space Occupying Lesion
【24h】

Clinical Experience with Frameless Neuronavigation Guided Biopsy for Intracranial Space Occupying Lesion

机译:颅内占位性病变无框神经导航引导活检的临床经验

获取原文
           

摘要

Biopsy is mandatory for histological diagnosis of non-resectable brain tumors. Of various techniques, neuronavigation guided biopsy provides intraoperative real-time reference and allows biopsy from multiple trajectories. The aim of this study is to assess the efficacy and accuracy of frameless neuronavigation biopsy. We retrospectively reviewed the medical archives of patients with intracranial space occupying lesion who underwent frameless neuronavigation biopsy at our institute between 2016 to 2018. All operations were performed under general anesthesia. Data were analyzed by SPSS version 20. P value of 0.05 was considered significant. There were 46 patients who underwent neuronavigation guided biopsy over the period of two years. Median age of patients was 46.5 years. Supratentorial tumors accounted for 95.8% of cases. Mean tumor diameter was 3.35 cm. Accuracy was 89.1%. More than half were glial tumors. Histopathology was inconclusive in 10.9% cases. Complication rate was 4.3%: one tract hematoma and one new neurological deficit. Frameless neuronavigation guided biopsy of intracranial space occupying lesion is safe and efficacious procedure with high diagnostic yield.
机译:对于不可切除的脑肿瘤的组织学诊断,必须进行活检。在各种技术中,神经导航引导的活检提供术中实时参考,并允许从多个轨迹进行活检。这项研究的目的是评估无框架神经导航活检的有效性和准确性。我们回顾性研究了2016年至2018年间在我院接受无框架神经导航活检的颅内占位病变患者的医学档案。所有手术均在全身麻醉下进行。数据通过SPSS 20版进行分析。P值<0.05被认为是显着的。在两年的时间内,有46例接受了神经导航引导活检的患者。患者的中位年龄为46.5岁。幕上肿瘤占病例的95.8%。平均肿瘤直径为3.35cm。准确度是89.1%。超过一半是神经胶质瘤。在10.9%的病例中组织病理学尚无定论。并发症发生率为4.3%:1例血肿和1例新的神经功能缺损。颅内占位性病变的无框神经导航引导活检是安全有效的方法,诊断率高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号